APA (7th ed.) Citation

C, B., KP, R., A, R., GAAM, S., CS, B., SW, N., . . . IHJT, d. H. (2023). Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial. Annals of surgical oncology, 30(5), 2678. https://doi.org/10.1245/s10434-023-13116-z

Chicago Style (17th ed.) Citation

C, Bakkers, et al. "Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial." Annals of Surgical Oncology 30, no. 5 (2023): 2678. https://doi.org/10.1245/s10434-023-13116-z.

MLA (9th ed.) Citation

C, Bakkers, et al. "Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial." Annals of Surgical Oncology, vol. 30, no. 5, 2023, p. 2678, https://doi.org/10.1245/s10434-023-13116-z.